Review Article
A Review of the Genetics and Pathogenesis of Syndactyly in Humans and Experimental Animals: A 3-Step Pathway of Pathogenesis
Table 3
Other types of syndactyly with a unique pathway of pathogenesis or with an undetermined pathogenesis.
| Type of syndactyly | Animals or humans | Gene mutation/knockout | Proposed pathogenesis as per our literature review |
| Poland syndrome (OMIM 173800) | Humans | ā | Unique pathway: vascular insult to the subclavian artery during the 19th embryonic stage | Shaker syndactyly | Mice | Fbn2 | Fibrillin-Fibulin interactions leading to increased Fgf8 activity (step II) | Type 9 human syndactyly (OMIM 609432) and mice deficient in BhLha9 | Humans/mice | Loss-of-function mutations of BHLHA9 and deletion of the murine ortholog Bhlha9 | Either through suppression of Notch signaling (step II, see Table 2) or disturbance of the apoptotic signal (step III) | Noggin-null mice | Mice | Nog | The overexpression of Ihh in the interdigital spaces leading to reduced apoptosis (step III) | Sp6 mutant mice | Mice | Sp6 | The mild deficiency in Fgf8 leads to overexpression of Fgf4 in the AER resulting in syndactyly | Type 8 human syndactyly (OMIM 309630) | Humans | FGF16 | Either via altering the expression of FGF8 or SHH |
|
|
AER: apical ectodermal ridge.
|